1. Abdool Karim SS, Abdool Karim Q, Kharsany AB, Baxter C, Grobler AC, Werner L, Kashuba A, Mansoor LE, Samsunder N, Mindel A, Gengiah TN, CAPRISA 004 Trial Group (2015) Tenofovir gel for the prevention of herpes simplex virus type 2 Infection. N Engl J Med 373:530–539
2. Bieber T, Chosidow O, Bodsworth N, Tyring S, Hercogova J, Bloch M, Davis M, Lewis M, Boutolleau D, Attali P, LIP Study Group (2014) Efficacy and safety of aciclovir mucoadhesive buccal tablet in immunocompetent patients with labial herpes (LIP Trial): a double-blind, placebo-controlled, self-initiated trial. J Drugs Dermatol 13:791–798
3. Birkmann A (2016) Zimmermann H. HSV antivirals – current and future treatment options. Curr Opin Virol 18:9–13
4. Böer A, Herder N, Winter K, Falk T (2006) Herpes folliculitis: clinical, histopathological, and molecular pathologic observations. Br J Dermatol 154:743–746
5. Chi CC, Wang SH, Delamere FM, Wojnarowska F, Peters MC, Kanjirath PP (2015) Interventions for prevention of herpes simplex labialis (cold sores on the lips). Cochrane Database Syst Rev. doi:
10.1002/14651858.cd010095.pub2